Bioneer A/S, Kogle Allé 2, 2970 Hørsholm, Denmark.
AbbVie Deutschland GmbH & Co.KG, Neuroscience Discovery, Knollstrasse, 67061 Ludwigshafen, Germany.
Stem Cell Res. 2021 Apr;52:102180. doi: 10.1016/j.scr.2021.102180. Epub 2021 Feb 2.
APOE genotype is the strongest genetic risk factor for Alzheimer's Disease (AD). The low degree of homology between mouse and human APOE is a concerning issue in preclinical models currently used to study the role of this gene in AD pathophysiology. A key objective of ADAPTED (Alzheimer's Disease Apolipoprotein Pathology for Treatment Elucidation and Development) project was to generate in vitro models that better recapitulate human APOE biology. We describe a new set of induced pluripotent stem cells (iPSC) lines carrying common APOE variants (Ɛ2, Ɛ3, and Ɛ3/Ɛ4) and a knock-out isogenic to the parental APOE Ɛ4/Ɛ4 line (UKBi011-A).
载脂蛋白 E 基因型是阿尔茨海默病 (AD) 的最强遗传风险因素。目前用于研究该基因在 AD 病理生理学中作用的临床前模型中,鼠与人载脂蛋白 E 的低度同源性是一个令人关注的问题。ADAPTED(阿尔茨海默病载脂蛋白病理用于治疗阐明和开发)项目的一个主要目标是生成更好地再现人类载脂蛋白 E 生物学的体外模型。我们描述了一组新的诱导多能干细胞 (iPSC) 系,携带常见的载脂蛋白 E 变体 (Ɛ2、Ɛ3 和 Ɛ3/Ɛ4) 以及与亲本载脂蛋白 E Ɛ4/Ɛ4 系 (UKBi011-A) 同源缺失的基因敲除系。